Nabilone 0.25 mg

DRUG2 trials

Sponsors

Medical University Innsbruck

Conditions

Parkinson Disease

Phase 2

Nabilone for Non-motor Symptoms in Parkinson's Disease

CompletedNCT03769896

Medical University InnsbruckParkinson Disease

Start: 2017-10-03End: 2019-07-15Updated: 2021-03-02

Phase 3

Nabilone for Non-motor Symptoms in Parkinson's Disease

CompletedNCT03773796

Medical University InnsbruckParkinson Disease

Start: 2018-08-06End: 2020-01-31Updated: 2021-03-02

Related Papers

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of <scp>NMS‐Nab</scp> Study

Movement Disorders Clinical Practice2022-05-1521 citations

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone

Annals of Neurology2020-08-05105 citations